Addition of oral iron bisglycinate to intravenous iron sucrose for the treatment of postpartum anemia - Randomized controlled trial
American Journal of Obstetrics and Gynecology Jun 25, 2021
Yefet E, Rabah SM, Sela ND, et al. - Via performing a randomized controlled trial, researchers aimed at comparing the efficacy of intravenous iron sucrose alone vs intravenous iron sucrose in combination with oral iron bisglycinate supplementation in treating moderate to severe postpartum anemia. Of 158 participants, 63 women receiving intravenous and oral iron and 44 women receiving intravenous iron only, completed the study and were incorporated in the analysis. Outcomes support intravenous 500 mg iron sucrose treatment alone as sufficient to manage postpartum anemia with no necessity of adding oral iron treatment.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries